Review Assesses KELIM Score to Guide Bevacizumab in Advanced Ovarian Cancer
A narrative review evaluates trial evidence indicating that KELIM chemosensitivity scores, rather than BRCA or homologous recombination deficiency status, predict ...
A narrative review evaluates trial evidence indicating that KELIM chemosensitivity scores, rather than BRCA or homologous recombination deficiency status, predict ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.